Immunovant Inc.
IMVT | NASDAQ
$37.18
+$0.23 (+0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$37.08
-$0.10 (-0.27%)
Pre-market:
Sep 22, 2026, 5:14 AM ET
TTM Period Ending | Q1 2027 Jun 29, 2026 | Q4 2026 Mar 30, 2026 | Q3 2026 Dec 30, 2025 | Q2 2026 Sep 29, 2025 | Q1 2026 Jun 29, 2025 | Q4 2025 Mar 30, 2025 | Q3 2025 Dec 30, 2024 | Q2 2025 Sep 29, 2024 | Q1 2025 Jun 29, 2024 | Q4 2024 Mar 30, 2024 | Q3 2024 Dec 30, 2023 | Q2 2024 Sep 29, 2023 | Q1 2024 Jun 29, 2023 | Q4 2023 Mar 30, 2023 | Q3 2023 Dec 30, 2022 | Q2 2023 Sep 29, 2022 | Q1 2023 Jun 29, 2022 | Q4 2022 Mar 30, 2022 | Q3 2022 Dec 30, 2021 | Q2 2022 Sep 29, 2021 | Q1 2022 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 206K | 206K | 206K | 105K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 6.89M | -206K | -206K | -105K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -558.91M | -532.9M | -487.17M | -487.11M | -471.09M | -438.15M | -405.21M | -352.46M | -298.51M | -270.21M | -253.59M | -246.06M | -233.88M | -208.28M | -191.24M | -178.49M | -166.52M | -156.03M | -137.72M | -128.09M | -111.42M |
Interest Income | 18.99M | 25.33M | 24.16M | 23.42M | 23.89M | 24.73M | 26.22M | 30.57M | 28.06M | 24.95M | 20.05M | 14.06M | 11.64M | 7.58M | 4.1M | 1.15M | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -538.92M | -505.39M | -460.56M | -462.44M | -445.58M | -412.95M | -382.17M | -322.73M | -271.89M | -258.77M | -244.11M | -255.42M | -244.88M | -210.95M | -197.71M | -176.26M | -166.32M | -156.81M | -137.87M | -128.63M | -111.64M |
Net Income | -538.22M | -505.61M | -464.2M | -464.69M | -447.3M | -413.84M | -382.71M | -323.01M | -272.55M | -259.34M | -243.45M | -255.26M | -244.52M | -210.96M | -198.7M | -176.86M | -166.63M | -156.73M | -137.72M | -128.11M | -111.19M |
Selling & General & Admin | 67.91M | 76.24M | 79.15M | 83.49M | 84.45M | 77.24M | 71.88M | 65.32M | 60.69M | 57.28M | 54.88M | 53.44M | 51.47M | 48.02M | 50.84M | 50.58M | 54.99M | 54.23M | 49.29M | 48.32M | 41.03M |
Research & Development | 498.09M | 456.66M | 408.02M | 403.62M | 386.64M | 360.92M | 333.32M | 287.14M | 237.83M | 212.93M | 198.71M | 192.62M | 182.4M | 160.26M | 140.41M | 127.91M | 111.53M | 101.81M | 88.44M | 79.77M | 70.39M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 566M | 532.9M | 487.17M | 487.11M | 471.09M | 438.15M | 405.21M | 352.46M | 298.51M | 270.21M | 253.59M | 246.06M | 233.88M | 208.28M | 191.24M | 178.49M | 166.52M | 156.03M | 137.72M | 128.09M | 111.42M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 566M | 532.9M | 487.17M | 487.11M | 471.09M | 438.15M | 405.21M | 352.46M | 298.51M | 270.21M | 253.59M | 246.06M | 233.88M | 208.28M | 191.24M | 178.49M | 166.52M | 156.03M | 137.72M | 128.09M | 111.42M |
Income Tax Expense | -698K | 215K | 3.64M | 2.24M | 1.73M | 890K | 539K | 279K | 655K | 567K | -656K | -161K | -354K | 9K | 988K | 601K | 309K | -84K | -151K | -518K | -447K |
Shares Outstanding (Basic) | 205.55M | 203.71M | 181.51M | 173.64M | 170.87M | 151.57M | 146.92M | 146.47M | 146.09M | 145.36M | 144.52M | 131.16M | 130.5M | 129.63M | 128.57M | 116.57M | 116.56M | 116.34M | 115.03M | 109.08M | 97.98M |
Shares Outstanding (Diluted) | 205.55M | 203.71M | 181.51M | 173.64M | 170.87M | 151.57M | 146.92M | 146.47M | 146.09M | 145.36M | 144.52M | 131.16M | 130.5M | 129.63M | 128.57M | 116.57M | 116.56M | 116.34M | 115.03M | 109.08M | 97.98M |
EPS (Basic) | -2.82 | -2.78 | -2.69 | -2.84 | -2.85 | -2.74 | -2.62 | -2.22 | -1.93 | -1.90 | -1.84 | -1.97 | -1.93 | -1.71 | -1.66 | -1.53 | -1.47 | -1.43 | -1.31 | -1.27 | -1.13 |
EPS (Diluted) | -2.82 | -2.78 | -2.69 | -2.84 | -2.85 | -2.74 | -2.62 | -2.22 | -1.93 | -1.90 | -1.84 | -1.97 | -1.93 | -1.71 | -1.66 | -1.53 | -1.47 | -1.43 | -1.31 | -1.27 | -1.13 |
EBITDA | -538.52M | -504.98M | -460.14M | -462.02M | -445.17M | -412.57M | -381.84M | -322.44M | -271.64M | -258.54M | -243.88M | -255.21M | -244.68M | -210.76M | -197.53M | -176.09M | -166.18M | -156.69M | -137.76M | -128.03M | -111.28M |
EBIT | -538.92M | -505.39M | -460.56M | -462.44M | -445.58M | -412.95M | -382.17M | -322.73M | -271.89M | -258.77M | -244.11M | -255.42M | -244.88M | -210.95M | -197.71M | -176.26M | -166.32M | -156.81M | -137.87M | -128.12M | -111.36M |
Depreciation & Amortization | 394K | 409K | 422K | 420K | 404K | 377K | 332K | 291K | 258K | 231K | 221K | 212K | 202K | 193K | 178K | 162K | 144K | 126K | 109K | 95K | 81K |
Add to Watchlist
Select watchlists to add or remove IMVT